Boreal Genomics announces completion of $18 million Series C financing round Boreal Genomics canadian pharmacy online.

Boreal Genomics announces completion of $18 million Series C financing round Boreal Genomics, a privately kept provider of technology for noninvasive genomic profiling of tumors from blood plasma of cancer tumor patients, declared today the completion of an $18 million Series C financing round canadian pharmacy online . The funding will be utilized to expand commercial procedures in the translational analysis market, scale laboratory features and launch scientific applications for non-invasive genomic profiling and monitoring of malignancy. The financing contains existing traders ARCH Venture Partners, Kearny Venture Companions and fresh undisclosed strategic and personal investors.

Other entries from category "laboratory":

Random entries